- Home
- ETON vs CRT Comparison
ETON vs CRT Comparison
Compare ETON & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- CRT
- Stock Information
- Founded
- ETON 2017
- CRT 1991
- Country
- ETON United States
- CRT United States
- Employees
- ETON N/A
- CRT N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- CRT Oil & Gas Production
- Sector
- ETON Health Care
- CRT Energy
- Exchange
- ETON Nasdaq
- CRT Nasdaq
- Market Cap
- ETON 388.3M
- CRT 65.1M
- IPO Year
- ETON 2018
- CRT 1992
- Fundamental
- Price
- ETON $18.46
- CRT $7.82
- Analyst Decision
- ETON Strong Buy
- CRT
- Analyst Count
- ETON 3
- CRT 0
- Target Price
- ETON $29.67
- CRT N/A
- AVG Volume (30 Days)
- ETON 205.9K
- CRT 23.9K
- Earning Date
- ETON 11-11-2025
- CRT 01-01-0001
- Dividend Yield
- ETON N/A
- CRT 11.39%
- EPS Growth
- ETON N/A
- CRT N/A
- EPS
- ETON N/A
- CRT 0.92
- Revenue
- ETON $58,181,000.00
- CRT $6,559,820.00
- Revenue This Year
- ETON $105.25
- CRT N/A
- Revenue Next Year
- ETON $40.84
- CRT N/A
- P/E Ratio
- ETON N/A
- CRT $8.44
- Revenue Growth
- ETON 85.40
- CRT N/A
- 52 Week Low
- ETON $5.35
- CRT $7.67
- 52 Week High
- ETON $21.48
- CRT $13.31
- Technical
- Relative Strength Index (RSI)
- ETON 67.44
- CRT 23.60
- Support Level
- ETON $17.24
- CRT $8.46
- Resistance Level
- ETON $18.52
- CRT $7.87
- Average True Range (ATR)
- ETON 0.70
- CRT 0.17
- MACD
- ETON -0.02
- CRT -0.06
- Stochastic Oscillator
- ETON 93.16
- CRT 12.72
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.